Archives
-
PPZ1–TORC1 Signaling in Candida Ferroptosis
2026-10-05
The reference study identifies the fungus-specific phosphatase PPZ1 as a regulator of TORC1 signaling, autophagy, ferroptosis sensitivity, and antifungal resistance in Candida albicans. Its findings support a fungal ferroptosis framework, while also showing why pathway-specific validation is needed before translating the concept into antifungal therapy.
-
PA-824: Mechanism and TB Research Evidence
2026-10-05
PA-824 is a bicyclic nitroimidazole derivative studied as a tuberculosis research compound and Mycobacterium tuberculosis inhibitor. Current evidence connects pretomanid activity with cell-wall biosynthesis, nitric oxide-linked respiratory disruption, and inhibition of terminal oxidase branches, while direct molecular targets and clinical applicability remain bounded by study context.
-
Ethacridine Lactate Monohydrate in Assay Integrity
2026-10-04
A source-grounded analysis of how Ethacridine lactate monohydrate may fit contamination-aware epigenetic research, using YAP–TEAD regulation of surface ectoderm commitment as a translational case study while separating assay integrity from biological mechanism.
-
2′-O-Methyl RNA Fragments and TLR7/8 Autoimmunity
2026-10-03
Alharbi and colleagues identify 5′-end 2′-O-methyl guanosine RNA fragments as antagonists of TLR7 and TLR8, revealing a previously unrecognized checkpoint in self-RNA discrimination. Structural, functional, in vivo, and human genetic evidence connects this mechanism to protection from aberrant innate immune activation and to selected autoimmune phenotypes.
-
Cell Death Mechanisms in Liver Disease
2026-10-01
This review reframes hepatocyte death as an active driver of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma rather than merely a marker of liver injury. Its central contribution is the integration of apoptosis, necrosis, necroptosis, damage-associated molecular patterns, clinical biomarkers, and disease-specific responses into a mechanistic framework for translational research.
-
BRD4–RAC1 Co-targeting in Breast Cancer
2026-10-01
The reference study identifies combined BRD4 and RAC1 inhibition as a subtype-aware strategy that suppresses breast cancer growth, stemness, migration, and tumorigenesis through disruption of the c-MYC–G9a–FTH1 axis and downregulation of HDAC1. Its integrated cellular, mechanistic, in vivo, and clinical analyses provide a framework for studying how transcriptional and chromatin regulators cooperate in breast cancer.
-
Griseofulvin: Reliable Microtubule Assay Workflows
2026-09-30
This scenario-based guide explains how Griseofulvin, SKU B3680, can support reproducible fungal mitosis, proliferation, and cytotoxicity workflows. It covers solvent compatibility, protocol design, mechanistic interpretation, and practical product-selection criteria grounded in product specifications and aneugenicity literature.
-
Biotin (Vitamin B7) for Motor-Protein Assays
2026-09-30
Biotin (Vitamin B7) connects affinity-based protein handling with mechanistic motor assays, but free biotin must be distinguished from activated biotinylation reagents. This workflow shows how to use A8010 for controlled competition, enzymatic studies, and streptavidin-compatible labeling strategies when dissecting BicD, MAP7, and kinesin-1 function.
-
BI-1347: Reliable Inhibitor Workflows
2026-09-29
Learn how BI-1347 (SKU BA3756) can support reproducible cell viability, proliferation, cytotoxicity, and molecular-target inhibition studies. This scenario-driven guide separates product-backed specifications from optimization decisions and connects CDK8/19 research findings with practical laboratory controls.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-29
Hydroxychloroquine Sulfate (SKU B4874) provides a water-soluble research reagent for controlled studies of autophagy pathway modulation and TLR7/9-associated immune signaling. It is appropriate for locally validated cell and animal workflows, but not for DMSO- or ethanol-based stocks or long-term storage of prepared solutions.
-
Reading the mRNA Delivery Bottleneck
2026-09-28
A mechanistic guide to using EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) to separate cellular uptake from productive translation, interpret protein-corona effects, and improve translational mRNA delivery decisions.
-
HAX1 Links SARS-CoV-2 Spike to the Host UPR
2026-09-28
The study identifies HAX1 as a binding partner of the SARS-CoV-2 spike S1 subunit and a necessary regulator of spike-associated unfolded protein response activation. Its findings connect this response with control of reactive oxygen species and mitochondrial function, while showing that HAX1 dependence is not a general feature of every ER stress stimulus.
-
RP3-340N1.2 Stabilizes IL-6 in NSCLC
2026-09-27
The study identifies the lncRNA RP3-340N1.2 as a regulator of IL-6 mRNA stability in non-small cell lung cancer (NSCLC). Its knockdown increased ZC3H12A association with IL-6 mRNA, promoted IL-6 mRNA decay, and reduced cancer-cell and macrophage-associated tumor-promoting effects in the tested systems.
-
Type III Collagen Restricts Breast Cancer Progression
2026-09-26
A 2024 study combines cell culture, human tumor analyses, three-dimensional models, and mouse experiments to investigate type III collagen (Col3) as a tumor-restrictive component of the breast cancer microenvironment. Its findings link higher Col3 relative to type I collagen with less aggressive tumor behavior and better patient survival, while suggesting that collagen composition merits further study as a therapeutic variable.
-
HBsAg Rewires TBK1 to Suppress IFN, Promote Autophagy
2026-09-25
This study reports that hepatitis B surface antigen (HBsAg) alters TBK1 signaling in a way that weakens type I interferon production while promoting autophagosome accumulation. Its mechanistic findings connect TBK1 dimerization, disrupted TBK1–IRF3 association, p62 phosphorylation, and impaired autophagosome–lysosome fusion, offering a framework for investigating HBV persistence.